Print PDF


Biotech Patenting

Speaking Engagement

October 5-6, 2011

London, England


C5’s 21st Forum on Biotech Patenting brings together eminent in-house counsel from the world’s largest pharma and biotech companies and their expert legal advisors from a range of European, U.S. and emerging market jurisdictions. Finnegan's Elizabeth Doherty will present “How to Navigate through Antibody Claims and Personalized Medicine/Biomarkers in the U.S.” The conference will be held at the Sheraton Park Lane Hotel in London, England. For more information, or to register, please see C5’s website.

Doherty Ph.D., Elizabeth A.